Managed Care

 

Treating Psoriasis Patients With Biologic Agents

MANAGED CARE December 2003. © MediMedia USA
Peer-Reviewed

Treating Psoriasis Patients With Biologic Agents

Improved outcomes with new biologic agents are prompting physicians to integrate them into therapy for psoriasis patients.
David M. Pariser, MD
Professor, Department of Dermatology, Eastern Virginia Medical School, Norfolk, Va.
MANAGED CARE December 2003. ©MediMedia USA
Continuing Education

Improved outcomes with new biologic agents are prompting physicians to integrate them into therapy for psoriasis patients.

David M. Pariser, MD

Professor, Department of Dermatology, Eastern Virginia Medical School, Norfolk, Va.

The advent of biologic response modifiers for the treatment of psoriasis is bringing a dramatic shift in the way that dermatologists provide care for patients with this major chronic disease, which currently affects more than 4.5 million American adults (National Psoriasis Foundation [NPF] 2003).

Limited experience with these specialty drugs and their unique delivery methods have given rise to reluctance among some dermatologists to utilize these agents in the care of psoriasis patients. Yet the extremely positive results that we as dermatologists see increasingly in our patients who are receiving these novel drugs make it incumbent on us to establish their place in our practice.

Plaque psoriasis is a painful and disfiguring condition that has severe adverse effects. These negative effects extend to patient quality of life, as well as work, family, finances, social life, leisure activities, sexual relations, and physical and emotional well-being.

Includes commentary by Jeffrey Lenow, MD, JD, Associate Professor, Jefferson Medical College of Thomas Jefferson University

Continuing education credit is being made possible through an educational grant from Genentech.

Author correspondence:
David M. Pariser, MD
Professor, Department of Dermatology
Eastern Virginia Medical School
601 Medical Tower
Norfolk, VA 23507

Meetings

2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
6th Semi-Annual Diagnostic Coverage and Reimbursement Conference Boston December 4–5, 2014
Customer Analytics & Engagement in Health Insurance Chicago December 4–5, 2014
Pharmaceutical and Biotech Clinical Quality Assurance Conference Alexandria, VA December 4–5, 2014
9th Semi-Annual Medical Device Coverage and Reimbursement Conference San Diego December 5, 2014
8th Annual Medical Device Clinical Trials Conference Chicago December 8–9, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015